Jiangzhong Pharmaceutical Co (SHSE:600750) Change In Payables And Accrued Expense : ¥0 Mil (TTM As of Sep. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Jiangzhong Pharmaceutical Co Change In Payables And Accrued Expense?

Jiangzhong Pharmaceutical Co's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2024 was ¥0 Mil. It means Jiangzhong Pharmaceutical Co's Accounts Payable & Accrued Expense stayed the same from Jun. 2024 to Sep. 2024 .

Jiangzhong Pharmaceutical Co's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was ¥0 Mil. It means Jiangzhong Pharmaceutical Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Dec. 2023 .

Jiangzhong Pharmaceutical Co Change In Payables And Accrued Expense Historical Data

The historical data trend for Jiangzhong Pharmaceutical Co's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangzhong Pharmaceutical Co Change In Payables And Accrued Expense Chart

Jiangzhong Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Jiangzhong Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Jiangzhong Pharmaceutical Co Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Jiangzhong Pharmaceutical Co Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Jiangzhong Pharmaceutical Co's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiangzhong Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangzhong Pharmaceutical Co Ltd (SHSE:600750) » Definitions » Change In Payables And Accrued Expense

Traded in Other Exchanges

N/A

Address

No. 788, Torch Avenue, High-tech Zone, Jiangxi Province, Nanchang, CHN, 330096

Website

http://www.jzjt.com

Jiangzhong Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is mainly engaged in producing and selling Chinese traditional medicines, healthcare food, and functional foods.

Executives

Lu Xiao Qing	Director
Xiao Wen Bin	Director
Zhang Xi He	Director
Cai Xin Ping	Director
Li Xiao Jun	Director
Tian Yong Jing	Director
Liu Wen Jun	Director
Xing Jian	Director
Xu Yong Qian	Director
Liu Wei Quan	Director

Jiangzhong Pharmaceutical Co Headlines

No Headlines